CONTEXT AND OBJECTIVES: The European Association of Urology Guideline Group for renal cell carcinoma (RCC) has prepared these guidelines to help clinicians assess the current evidence-based management of RCC and to incorporate the present recommendations into daily clinical practice. EVIDENCE ACQUISITION: The recommendations provided in the current updated guidelines are based on a thorough review of available RCC guidelines and review articles combined with a systematic literature search using Medline and the Cochrane Central Register of Controlled Trials. EVIDENCE SYNTHESIS: A number of recent prospective randomised studies concerning RCC are now available with a high level of evidence, whereas earlier publications were based on retrospective analyses, including some larger multicentre validation studies, meta-analyses, and well-designed controlled studies. CONCLUSIONS: These guidelines contain information for the treatment of an individual patient according to a current standardised general approach. Updated recommendations concerning diagnosis, treatment, and follow-up can improve the clinical handling of patients with RCC. (c) 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
CONTEXT AND OBJECTIVES: The European Association of Urology Guideline Group for renal cell carcinoma (RCC) has prepared these guidelines to help clinicians assess the current evidence-based management of RCC and to incorporate the present recommendations into daily clinical practice. EVIDENCE ACQUISITION: The recommendations provided in the current updated guidelines are based on a thorough review of available RCC guidelines and review articles combined with a systematic literature search using Medline and the Cochrane Central Register of Controlled Trials. EVIDENCE SYNTHESIS: A number of recent prospective randomised studies concerning RCC are now available with a high level of evidence, whereas earlier publications were based on retrospective analyses, including some larger multicentre validation studies, meta-analyses, and well-designed controlled studies. CONCLUSIONS: These guidelines contain information for the treatment of an individual patient according to a current standardised general approach. Updated recommendations concerning diagnosis, treatment, and follow-up can improve the clinical handling of patients with RCC. (c) 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Authors: Katharina Sell; Peter J Barth; Roland Moll; Martin A Thomas; Nadine Zimmer; Ecatarina Oplesch; Michael Gudo; Mark Schrader; Rainer Hofmann; Andres Jan Schrader Journal: Tumour Biol Date: 2011-12-06
Authors: Milan Hora; Petr Stránský; Ivan Trávníček; Tomáš Urge; Viktor Eret; Boris Kreuzberg; Jan Baxa; Hynek Mírka; Fredrik Petersson; Ondřej Hes; Jiří Ferda Journal: World J Urol Date: 2012-04-19 Impact factor: 4.226
Authors: Krishnendu Pal; Ying Cao; Irina N Gaisina; Santanu Bhattacharya; Shamit K Dutta; Enfeng Wang; Hendra Gunosewoyo; Alan P Kozikowski; Daniel D Billadeau; Debabrata Mukhopadhyay Journal: Mol Cancer Ther Date: 2013-12-10 Impact factor: 6.261
Authors: John T Leppert; Janet Hanley; Todd H Wagner; Benjamin I Chung; Sandy Srinivas; Glenn M Chertow; James D Brooks; Christopher S Saigal Journal: Urology Date: 2014-02-12 Impact factor: 2.649
Authors: Axel Heidenreich; Stefan Wilop; Michael Pinkawa; Daniel Porres; David Pfister Journal: Dtsch Arztebl Int Date: 2012-09-28 Impact factor: 5.594